Profile data is unavailable for this security.
About the company
Biofrontera Inc. is a biopharmaceutical company. The Company is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. In the United States, the PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses (AK) of mild-to-moderate severity on the face and scalp. Its second prescription drug licensed product in its portfolio is Xepi, which is a topical non-fluorinated quinolone that inhibits bacterial growth and used for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes.
- Revenue in USD (TTM)33.25m
- Net income in USD-23.09m
- Incorporated2015
- Employees85.00
- LocationBiofrontera Inc120 Presidential Way,, Suite 330WOBURN 01801United StatesUSA
- Phone+1 (781) 245-1325
- Fax+1 (302) 655-5049
- Websitehttps://www.biofrontera-us.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sonnet Biotherapeutics Holdings Inc | 92.74k | -8.43m | 4.47m | 12.00 | -- | 0.8727 | -- | 48.19 | -5.28 | -5.28 | 0.0315 | 0.9813 | 0.0097 | -- | 0.2248 | 7,728.33 | -87.68 | -- | -194.11 | -- | -- | -- | -9,086.22 | -- | -- | -138.21 | 0.00 | -- | -57.76 | -- | 36.64 | -- | -- | -- |
| Processa Pharmaceuticals Inc | 0.00 | -9.83m | 4.86m | 13.00 | -- | 0.5466 | -- | -- | -6.29 | -6.29 | 0.00 | 3.11 | 0.00 | -- | -- | 0.00 | -87.82 | -84.35 | -102.32 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0012 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Titan Pharmaceuticals Inc | 87.00k | -4.95m | 5.22m | 4.00 | -- | 0.8569 | -- | 59.94 | -6.41 | -6.41 | 0.1119 | 6.66 | 0.0197 | -- | 1.23 | 21,750.00 | -112.41 | -96.80 | -170.59 | -156.65 | -- | -- | -5,694.25 | -406.26 | -- | -415.19 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Stemtech Corp | 5.17m | -4.61m | 5.79m | 45.00 | -- | -- | -- | 1.12 | -0.0482 | -0.0482 | 0.0543 | -0.0319 | 1.27 | 13.23 | 80.02 | -- | -113.00 | -- | -- | -- | 78.68 | -- | -89.26 | -- | 0.0563 | -4.06 | -- | -- | 7.94 | -- | 36.45 | -- | -- | -- |
| Sonoma Pharmaceuticals Inc | 12.74m | -4.84m | 5.82m | 172.00 | -- | 0.7782 | -- | 0.4566 | -0.7237 | -0.7237 | 1.40 | 0.3932 | 0.8224 | 2.87 | 4.66 | 74,040.70 | -31.22 | -29.36 | -41.09 | -40.65 | 37.26 | 38.00 | -37.97 | -30.93 | 2.64 | -- | 0.05 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
| GT Biopharma Inc | 0.00 | -9.64m | 5.91m | 2.00 | -- | 0.7123 | -- | -- | -7.04 | -7.04 | 0.00 | 3.85 | 0.00 | -- | -- | 0.00 | -64.24 | -205.36 | -90.39 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 63.62 | -- | -- | -- |
| Integrated BioPharma, Inc. | 50.57m | -116.00k | 6.02m | 141.00 | -- | 0.3183 | 28.40 | 0.119 | -0.0041 | -0.0041 | 1.67 | 0.6283 | 1.88 | 4.45 | 10.76 | 358,617.00 | -0.431 | 15.51 | -0.5698 | 27.94 | 7.09 | 12.09 | -0.2294 | 6.44 | 1.02 | -9.00 | 0.001 | -- | -9.91 | 3.00 | -101.35 | -- | -14.03 | -- |
| Sentient Brands Holdings Inc | 0.00 | -818.63k | 6.10m | 2.00 | -- | -- | -- | -- | -0.0145 | -0.0145 | 0.00 | -0.036 | 0.00 | 0.0188 | -- | 0.00 | -317.87 | -220.36 | -- | -- | -- | 41.81 | -- | -31,451.19 | 0.0354 | -2.27 | -- | -- | -73.68 | -- | 34.98 | -- | -- | -- |
| Biofrontera Inc | 33.25m | -23.09m | 6.26m | 85.00 | -- | -- | -- | 0.1883 | -12.47 | -12.47 | 16.84 | -0.3627 | 0.9995 | 2.50 | 5.75 | 391,200.00 | -69.40 | -- | -144.06 | -- | 48.99 | -- | -69.44 | -- | 0.944 | -3.55 | 4.63 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
| Shuttle Pharmaceuticals Holdings Inc | 0.00 | -7.35m | 6.72m | 8.00 | -- | 2.44 | -- | -- | -0.4739 | -0.4739 | 0.00 | 0.1642 | 0.00 | -- | -- | 0.00 | -96.75 | -- | -119.37 | -- | -- | -- | -- | -- | -- | -5.28 | 0.2542 | -- | -- | -- | -112.71 | -- | -- | -- |
| Sunshine Biopharma Inc | 26.74m | -4.09m | 6.89m | 44.00 | -- | 0.0118 | -- | 0.2577 | -13.35 | -13.35 | 76.96 | 24.96 | 0.9081 | 3.13 | 11.58 | 607,722.50 | -13.88 | -101.52 | -17.99 | -137.04 | 33.15 | 35.47 | -15.29 | -165.33 | 3.23 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
| Cannapharmarx Inc | 25.84k | -6.61m | 7.29m | 21.00 | -- | -- | -- | 282.02 | -0.0205 | -0.0205 | 0.00008 | -0.0425 | 0.0031 | -- | 0.4503 | 1,230.48 | -79.52 | -131.06 | -- | -- | -1,692.76 | -- | -25,598.30 | -- | 0.0033 | -0.1306 | -- | -- | -- | -- | 143.24 | -- | -- | -- |
| Vestiage Inc | 0.00 | -21.76k | 7.70m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0011 | 0.00 | -- | -- | -- | -4,945.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -102.30 | -- | -- | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 8.08m | 233.00 | 0.0542 | 0.0008 | 2.09 | 0.1142 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Bon Natural Life Ltd | 29.52m | 4.60m | 8.09m | 96.00 | 0.4082 | 0.0674 | 1.47 | 0.274 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
Data as of Jul 30 2024. Currency figures normalised to Biofrontera Inc's reporting currency: US Dollar USD
22.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rosalind Advisors, Inc.as of 30 Jun 2024 | 504.26k | 9.91% |
| AIGH Capital Management LLCas of 15 Apr 2024 | 501.43k | 9.85% |
| Matejka & Partner Asset Management GmbHas of 28 Mar 2024 | 63.80k | 1.25% |
| Scotia Capital, Inc. (Broker)as of 31 Mar 2024 | 40.00k | 0.79% |
| XTX Markets LLCas of 31 Mar 2024 | 12.19k | 0.24% |
| HRT Financial LLCas of 31 Mar 2024 | 10.64k | 0.21% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 10.22k | 0.20% |
| amandea Verm�gensverwaltung AGas of 31 Dec 2022 | 10.00k | 0.20% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 4.62k | 0.09% |
| Tower Research Capital LLCas of 31 Mar 2024 | 1.91k | 0.04% |
More ▼
Data from 28 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
